Complement protective epitopes and CD55-microtubule complexes facilitate the invasion and intracellular persistence of uropathogenic escherichia coli

Journal of Infectious Diseases

Volumn 209, Issue 7, 2014, Pages 1066-1076

  Rana, Tanu ^a   Hasan, Rafia J ^a   Nowicki, Stella ^a   Venkatarajan, Mathura S ^d   Singh, Rajbir ^a   Urvil, Petri T ^a   Popov, Vsevolod ^c   Braun, Werner A ^a   Popik, Waldemar ^a   Goodwin, J Shawn ^b   Nowicki, Bogdan J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c Department of Cancer Biology Meharry Medical College ^*  (United States)

^d ROSKAMP INSTITUTE   (United States)

Author keywords

CD55; intracellular persistence; invasion; microtubules

Indexed keywords

COMPLEMENT; DECAY ACCELERATING FACTOR; EPITOPE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BACTERIAL REPRODUCTION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CELL INVASION; CHO CELL; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; INTERNALIZATION; MICROTUBULE; MOLECULAR MODEL; NONHUMAN; PHAGOLYSOSOME; POINT MUTATION; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; UROPATHOGENIC ESCHERICHIA COLI;

CD55; DR+ E. COLI; INTRACELLULAR PERSISTENCE; INVASION; MICROTUBULES;

ADHESINS, ESCHERICHIA COLI; ANIMALS; ANTIGENS, CD55; CHO CELLS; COMPLEMENT SYSTEM PROTEINS; CRICETULUS; ENDOCYTOSIS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MICROTUBULES; MUTANT PROTEINS; PROTEIN CONFORMATION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 84898932470     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit619     Document Type: Article

References (37)

1. Nowicki B, Truong L, Moulds J, Hull R. Presence of the Dr receptor in normal human tissues and its possible role in the pathogenesis of ascending urinary tract infection. Am J Pathol 1988; 133:1-4
2. Hart A, Nowicki BJ, Reisner B, et al. Ampicillin-resistant Escherichia coli in gestational pyelonephritis: Increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis 2001; 183:1526-9. (Pubitemid 32417705
3. Greer LG, Roberts SW, Sheffield JS, et al. Ampicillin resistance and outcome differences in acute antepartum pyelonephritis. Infect Dis Obs Gyn 2008; doi:10.1155/2008/891426
4. Rizvi M, Khan F, Shukla I, Malik A, Shaheen . Rising prevalence of antimicrobial resistance in urinary tract infections during pregnancy: Necessity for exploring newer treatment options. J Lab Phys 2011; 3: 98-103
5. Hourcade D, Holers VM, Atkinson JP. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989; 45:381-416. (Pubitemid 19195511
6. Osuka F, Endo Y, Higuchi M, et al. Molecular cloning and characterization of novel splicing variants of human decay-Accelerating factor. Genomics 2006; 88:316-22. (Pubitemid 44278525
7. Wu J, Li H, Zhang S. Regulator of complement activation (RCA) group gene cluster in zebrafish: Identification, expression, and evolution. Funct Integr Gen 2012; 12:367-77
8. Hafenstein S, Bowman VD, Chipman PR, et al. Interaction of decay-Accelerating factor with coxsackievirus B3. J Virol 2007; 81: 12927-35. (Pubitemid 350156930
9. O'Brien DP, Romero-Gallo J, Schneider BG, et al. Regulation of the Helicobacter pylori cellular receptor decay-Accelerating factor. J Biol Chem 2008; 283:23922-30
10. Plevka P, Hafenstein S, Harris KG, et al. Interaction of decay-Accelerating factor with echovirus 7. J Virol 2010; 84:12665-74
11. Renois F, Hong SS, Le Naour R, et al. Development of a recombinant CHO cell model for the investigation of CAR and DAF role during early steps of echovirus 6 infection. Virus Res 2011; 158:46-54
12. Shafren DR, Bates RC, Agrez MV, Herd RL, Burns GF, Barry RD. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment. J Virol 1995; 69:3873-7
13. Sobo K, Rubbia-Brandt L, Brown TD, Stuart AD, McKee TA. Decayaccelerating factor binding determines the entry route of echovirus 11 in polarized epithelial cells. J Virol 2011; 85:12376-86
14. Williams DT, Chaudhry Y, Goodfellow IG, Lea S, Evans DJ. Interactions of decay-Accelerating factor (DAF) with haemagglutinating human enteroviruses: Utilizing variation in primate DAF to map virus binding sites. J Gen Virol 2004; 85:731-8. (Pubitemid 38379877
15. Selvarangan R, Goluszko P, Popov V, et al. Role of decay-Accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli. Infect Immun 2000; 68:1391-9. (Pubitemid 30108536
16. Hoepelman AI, Tuomanen EI. Consequences of microbial attachment: Directing host cell functions with adhesins. Infect Immun 1992; 60: 1729-33
17. Nowicki B, Hart A, Coyne KE, Lublin DM, Nowicki S. Short consensus repeat-3 domain of recombinant decay-Accelerating factor is recognized by Escherichia coli recombinant Dr adhesin in a model of a cell-cell interaction. J Exp Med 1993; 178:2115-21. (Pubitemid 23344868
18. Hasan RJ, Pawelczyk E, Urvil PT, et al. Structure-function analysis of decay-Accelerating factor: Identification of residues important for binding of the Escherichia coli Dr adhesin and complement regulation. Infect Immun 2002; 70:4485-93. (Pubitemid 34790960
19. Lublin DM, Thompson ES, Green AM, Levene C, Telen MJ. Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants. J Clin Invest 1991; 87:1945-52
20. Goluszko P, Popov V, Selvarangan R, Nowicki S, Pham T, Nowicki BJ. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J Infect Dis 1997; 176:158-67. (Pubitemid 27272864
21. Cersini A, Salvia AM, Bernardini ML. Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants. Infect Immun 1998; 66:549-57. (Pubitemid 28074194
22. Cossart P, Sansonetti PJ. Bacterial invasion: The paradigms of enteroinvasive pathogens. Science 2004; 304:242-8. (Pubitemid 38452169
23. Ray K, Marteyn B, Sansonetti PJ, Tang CM. Life on the inside: The intracellular lifestyle of cytosolic bacteria. Nat Rev Microbiol 2009; 7: 333-40
24. Gustafsdottir SM, Schallmeiner E, Fredriksson S, et al. Proximity ligation assays for sensitive and specific protein analyses. Anal Biochem 2005; 345:2-9. (Pubitemid 41558189
25. Barlow PN, Steinkasserer A, Norman DG, et al. Solution structure of a pair of complement modules by nuclear magnetic resonance. J Mol Biol 1993; 232:268-84. (Pubitemid 23245413
26. Fraczkiewicz R, Braun W. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J Comp Chem 1998; 19:319-33. (Pubitemid 128592649
27. Soman KV, Schein CH, Zhu H, Braun W. Homology modeling and simulations of nuclease structures. Methods Mol Biol 2001; 160: 263-86
28. Albert MJ, Faruque AS, Faruque SM, Sack RB, Mahalanabis D. Casecontrol study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol 1999; 37:3458-64. (Pubitemid 29491074
29. Girón JA, Jones T, Millán-Velasco F, et al. Diffuse-Adhering Escherichia coli (DAEC) as a putative cause of diarrhea in Mayan children in Mexico. J Infect Dis 1991; 163:507-13
30. Ishitoya S, Yamamoto S, Kanamaru S, . Distribution of afaE adhesins in Escherichia coli isolated from Japanese patients with urinary tract infection. J Urol 2003; 169:1758-61. (Pubitemid 36443490
31. Johnson JR, Owens K, Gajewski A, Kuskowski MA. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 2005; 43:6064-72. (Pubitemid 43100662
32. Kachroo BB. Association between antibiotic resistance and the expression of Dr adhesin among uropathogenic Escherichia coli. Chemotherapy 2001; 47:97-103. (Pubitemid 32149699
33. Nowicki B, Svanborg-Edén C, Hull R, Hull S. Molecular analysis and epidemiology of the Dr hemagglutinin of uropathogenic Escherichia coli. Infect Immun 1989; 57:446-51. (Pubitemid 19046366
34. Goluszko P, Moseley S, Truong LD, Kaul A, Nowicki S, Nowicki B. Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: Mutation in the dra region prevented tubulointerstitial nephritis. J Clin Invest 1997; 99: 1-11
35. Das M, Hart-Van Tassell A, Urvil PT, et al. Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion. Infect Immun 2005; 73:6119-26. (Pubitemid 41193051
36. Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev 2009; 89:73-120
37. Horvath DJ Jr, Li B, Casper T, et al. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli. Microbes Infect 2011; 13:426-37